À¯¸®Ã¼ÀýÁ¦¼ú°ú µ¿½Ã¿¡ ½ÃÇàÇÑ º£¹Ù½ÃÁÖ¸¿ ÁÖ»ç ÈÄ ¹ß»ýÇÑ À¯¸®Ã¼ ±×¹°¸Á
Vitreous Web after Pars Plana Vitrectomy and Bevacizumab Injection

´ëÇѾȰúÇÐȸÁö 2014³â 55±Ç 5È£ p.780 ~ p.784

±è¸ð¼¼(Kim Mo-Ses) - ÃæºÏ´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç
äÁÖº´(Chae Ju-Byung) - ÃæºÏ´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç

Abstract

¸ñÀû: ´ç´¢º´¼º À¯¸®Ã¼ÃâÇ÷·Î À¯¸®Ã¼ÀýÁ¦¼ú ¹× À¯¸®Ã¼°­ ³» º£¹Ù½ÃÁÖ¸¿ ÁÖ»ç ½ÃÇà ÈÄ À¯¸®Ã¼³»¿¡ ¹ß»ýÇÑ À¯¸®Ã¼ ±×¹°¸Á(vitreous web) ¿°Áõ 1¿¹¸¦ º¸°íÇϰíÀÚ ÇÑ´Ù.

Áõ·Ê¿ä¾à: ¾ç¾È ´ç´¢¸Á¸·º´ÁõÀ¸·Î ¹ü¸Á¸··¹ÀÌÀú±¤ÀÀ°í¼ú ÈÄ ¾È°ú¿Ü·¡¿¡ °æ°ú°üÂû ÁßÀÎ 41¼¼ ¿©ÀÚ È¯ÀÚ°¡ ¿ì¾È ½Ã·ÂÀúÇϸ¦ ÁÖ¼Ò·Î º´¿ø ¿¡ ³»¿øÇÏ¿´´Ù. ¼¼±Øµî °Ë»ç»ó ¿ì¾È¿¡ À¯¸®Ã¼ÃâÇ÷ º¸¿© ´ç´¢º´¼º À¯¸®Ã¼ÃâÇ÷ Áø´ÜÇÏ¿¡, À¯¸®Ã¼°­ ³» º£¹Ù½ÃÁÖ¸¿ Áֻ縦 µ¿¹ÝÇÑ À¯¸® üÀýÁ¦¼úÀ» ½ÃÇàÇÏ¿´´Ù. ¼ö¼ú ÈÄ 1Àϰ Àü¾ÈºÎ¿¡ ¿°Áõ¼Ò°ß ¾øÀÌ À¯¸®Ã¼ÃâÇ÷Àº ¸ðµÎ Á¦°ÅµÇ¾ú´Ù. ±×·¯³ª Àü¾ÈºÎ¿°Áõ ¾øÀÌ, À¯¸®Ã¼³»¿¡ ´Ù¹ß¼ºÀÇ Èò»öÀÇ À¯¸®Ã¼ ±×¹°¸Á ¿°ÁõÀÌ °üÂûµÇ¾ú´Ù. ºñ°¨¿°¼º À¯¸®Ã¼ ¿°Áõ Áø´ÜÇÏ¿¡ Åë»óÀûÀÎ Á¡¾È ½ºÅ×·ÎÀ̵åÁ¦ À̿ܿ¡ ¼Ò·®ÀÇ °æ±¸ ½ºÅ×·ÎÀ̵å Åõ¾àÀ» ½ÃÀÛÇÏ¿´´Ù. ¼ö¼ú ÈÄ 4Àϰ À¯¸®Ã¼ ±×¹°¸ÁÀº ¸ðµÎ »ç¶óÁ³´Ù. 1´Þ µÚ Á¾ȿ¡µµ ´ç´¢º´¼º À¯¸®Ã¼ÃâÇ÷ ¹ß»ýÇÏ¿´À¸¸ç, º£¹Ù½ÃÁÖ¸¿ ÁÖ»ç ¾øÀÌ À¯¸®Ã¼ÀýÁ¦¼ú ½ÃÇàÇÏ¿´°í, À¯¸®Ã¼ ±×¹°¸ÁÀº ¹ß»ýÇÏÁö ¾Ê¾Ò´Ù.

°á·Ð: ´ç´¢º´¼º À¯¸®Ã¼ÃâÇ÷·Î À¯¸®Ã¼ÀýÁ¦¼ú ¹× À¯¸®Ã¼°­ ³» º£¹Ù½ÃÁÖ¸¿ ÁÖ»ç ½ÃÇà Á÷ÈÄ¿¡ ÀϽÃÀû ÇÕº´ÁõÀ¸·Î, À¯¸®Ã¼ ±×¹°¸Á¸ð¾ç ¿°Áõ ÀÌ »ý±æ ¼ö ÀÖ´Ù. ÅëÁõ, °á¸·ÃæÇ÷, Àü¹æÃà³ó ¹× Àü¹æ³» ¿°Áõ¼¼Æ÷ µîÀÇ À¯¹«¸¦ È®ÀÎÇÏ¿© °¨¿°¿¡ ÀÇÇÑ À¯¸®Ã¼ ¿°ÁõÀ» ¹èÁ¦ÇÒ ¼ö ÀÖÀ¸¸é À¯¸®Ã¼ ±×¹°¸Á ¿°ÁõÀº ħ½ÀÀûÀÎ À¯¸®Ã¼°­ ³» Ç×»ýÁ¦ ÁÖ»ç ¾øÀ̵µ È£ÀüµÉ ¼ö ÀÖ´Ù.
À¯¸®Ã¼°­ ³» Ç×»ýÁ¦ ÁÖ»ç ¾øÀ̵µ È£ÀüµÉ ¼ö ÀÖ´Ù.
Purpose: To report a case of vitreous inflammation (vitreous web) after intravitreal bevacizumab injection accompanying pars plana vitrectomy (PPV) for the treatment of proliferative diabetic retinopathy with vitreous hemorrhage.

Case summary: A 41-year-old female who underwent panretinal photocoagulation for diabetes mellitus (DM) retinopathy presented with decreased visual acuity in her right eye which was caused by vitreous hemorrhage. The patient underwent PPV with intravitreal bevacizumab injection. One day after surgery, the vitreous hemorrhage cleared and there was no inflammation in the anterior segment; however, multiple inflammatory white strands (vitreous web) were found in the vitreous cavity. She was diagnosed with non-infectious endophthalmitis and treated with topical steroid and additional oral steroids, resulting in clearance of the vitreous web on postoperative day 4. One month later, vitreous hemorrhage occurred in the other eye. PPV without bevacizumab injection cleared the vitreous hemorrhage with no evidence of vitreous web.

Conclusions: Vitreous web-like inflammation can occur after intravitreal bevacizumab injection accompanying PPV for the treatment of DM vitreous hemorrhage. After eliminating infectious endophthalmitis based on lack of pain, conjunctival injection, anterior chamber hypopyon, and inflammatory cells, the web can be cleared without invasive intravitreal antibiotics injections.

Ű¿öµå

Intraocular inflammation, Vitreous hemorrhage
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå